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Fig. 1 Time-course of glutamate (Glu) release increased by capsaicin or high K+, The increase 
in fluorescence 1, 3 and 5 min after stimulation with 10 mM capsaicin or 80 mM KCl was 
quantified as Glu concentration in superficial laminae （・）, lamina X （・） and ventral horn (•), 




















200 Fig. 2 Effects of repeated systemic injections of 
[Asui.7]eel calcitonin (eCT) on formalin induced 
hyperalgesia. Vehicle or eCT was administered 
daily for 7 days and dilute formalin was adminis-
tered 15 min after the last injection of eCT. o : 
vehicle (n=l3), •:eCT (0.4 Ukg' day-＇， ηニ
12),+:eCT (4 Ukg-1day-1, n=l4), and 企：eCT
(40Ukg 'day 1, n二 12),Each point represents 
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Fig. 3 RT PCR for NK,receptor mRNA in the dorsal 
root ganglia of mice and the confirmation using 
nested PCR and digestion wih restriction enz戸nes.
A : RT-PCR of RNA from the dorsal root ganglia 
using four pairs of primers, NK, 1 plus NK, 6 (lane 
1), NK, 2 plus NK, -5 (lane 2), NK, -3 plus NK, -7 
(lane 3), and NK, -4 plus NK1一7(lane 4). M：φ174 
digested with Haem. B : Identification of the 264 bp 
PCR product (lane 1) by nested PCR using internal 
primers, NK, 4 and NK, 6 (lane 2). M : pBR322 
digested with Ms/JI. C: Identification of the PCR 
products by digestion with restriction enzmes (Stul, 
Hae II and Hinfl) . The restriction enzymes used are 
shown under the each lane. a. b. c. and d correspond 
with 1, 2, 3, and 4 in Fig. 3A, respectively. Ml：φ174 
digested with HaeIII : M2 : pBR322 digested with 










rats, intrathecal administration of I一（m-chloro-
phenyl) -biguanide, a selective 5 HT3 receptor 
agonist, facilitated the aversive responses in the 
second phase whereas that of 8-0H-DPAT, a selec司
tive 5 HTlA receptor agonist, suppressed them. 
Intrathecal administration of 5 HT showed a dual 
effect on the second phase of the aversive responses 
in the 5,7 DHT treated rats; 5 HT inhibited the 
aversive responses when administered at a low dose 
(0.1 nmol/rat) but facilitated them at a high dose (1 
nmol I rat). In addition, the inhibitory and 
facilitatory effects of intrathecal 5-HT were block-
ed by its co administration with NAN190, a 5 
HTlA receptor antagonist, and granisetron, respec-
tively. These results suggest that 5 HT suppresses 
formalin-induced nociception in the spinal cord via 
the 5 HTlA receptor and facilitates it via the 5-
HT3 receptor. 
2 ) Visualization of glutamate release from rat 
spinal cord with a conforcal laser scanning 
microscope. 
C. Tohda and Y. Kuraishi. Neurosci. Res., 24, 
183-187' 1996. 
Summary: Visualization of the release of an 
excitatory neurotransmitter, glutamate (Glu), from 
a slice preparation of the brain and spinal cord may 
be of great advantage in studying the release of Glu 
from a small population of neurons. When capsaicin 
(10 mM) was applied to a slice of the rat spinal cord 
immersed in a medium containing glutamate dehy-
drogenase ( GDH), an oxidized form of nicotin-
amide adenine dinucleotide (NAD+), and tetrodotox-
in, we observed an apparent increase of fluores-
cence in superficial laminae and lamina X, using a 
confocal laser scanning microscope. Such an 
increase was not observed in the absence of either 
NAD+ or GDH, inhibited by removal of extracel-
lular Ca2+, and abolished by capsazepine (100 mM). 
In contrast with capsaicin, Glu release evoked by 
high-K+ was observed in al laminae throughout the 
grey matter. The present results suggest that this 
system enables us to see the site of the release of 
Glu as an image and that capsaicin releases this 
amino acid mainly in superficial laminae and 
lamina X in the spinal cord. 
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Fig. 4 The expression chage of T A20 mRNA in devel-
oping rat brains. The relative expression levels of 
T A20 mRN A in the cerebral cortex ( o), 
hippocampus （ム） and cerebellum （ロ） are shown 
through the development. Quantified expression val-
ues of T A20 mRNA are shown as relative percent-
ages to a maximum intensity. Data are expressed as 




1 ) Dual effect of serotonin on formalin-induced 
nociception in the ra土spinalcord. 
T. Oyama, M. Ueda, Y. Kuraishi and M. 
Satoh. Neurosci. Res., 25, 129-135, 1996. 
Summary: To examine the role of the descending 
serotonergic system in the regulation of spinal 
nociceptive processing, the effects of serotonin (5-
HT) and selective ligands for 5 HT receptor 
subtypes on persistent nociception were inves-
tigated. Formalin (5 % formaldehyde) injected into 
the plantar region of the rat hindpaw induced two 
phases of aversive responses such as licking and 
biting. Intrathecal administration of selective 5 
HT3 receptor antagonists, granisetron (0.1 -100 
pmol I rat) and ondansetron (1 -1000 pmol I rat), 
reduced the second phase of the formalin induced 
aversive responses without affecting the first one. 
The antinociceptive effect of granisetron (100 pmol 
/rat) was abolished when 5-HT was depleted from 
the lumbar cord by pretreatment with 5,7-dihydroxy-
tryptamine (5,7-DHT). In the 5,7-DHT-treated 
I.天然薬物の抗侵害受容作用に関する研究
3 ) Antinociceptive effects of repeated systemic 
injections of calcitonin in folmalin-induced 
hyperalgesic rats. 
H. Umeno, T. Nagasawa, N. Yamazaki and Y. 
Kuraishi. Pharmacol. Biochem. Behav., 55, 151-
156, 1996. 
Summary: Calcitonin (CT) produces a long last-
ing analgesia in patients suffering from painful 
diseases following repeated systemic injections, but 
there have been few reports on the antinociceptive 
action of systemic injections of CTs in animal 
experiments. This study was conducted to elucidate 
an antinociceptive action of systemic CT in rats. 
An injection of dilute formalin induced hyperalgesia 
for about 2 h.Single topical injections of 0.12 and 
1.2 u, but not 0.012 u, of [Asu1・1]eel CT (eCT) into 
the same site of formalin injection inhibited the 
hyperalgesia. Repeated systemic injections of eCT 
(4 and 40, but not 0.4, u kg-1 day-1) for 7 days 
inhibited the hyperalgesia, while the single injection 
was without effects at doses tested. Although the 
highest dose of eCT (40 u kg-1 day-1) inhibited an 
increase in body weight following repeated injec-
tions, lower doses (0.4 and 4 u kg-1 day-1) were 
without effects. The antinociception following 
repeated systemic injections of eCT (4 u kg 1 day-1) 
lasted for at least 24 h, and subsided by 3 days 
following the last eCT injection. These results indi-
cate that the repeated systemic injections of eCT 
produce a long lasting inhibition of formalin in-
duced hyperalgesia in rats. This inhibitory effect is 
similar to CT analgesia in human subjects in terms 
of a necessity for repeated administration, effective 
dose and long-lasting effects. 
4 ) Processing of n田 vomica.VII. Antinocice・
ptive effects of crude alkaloids from the un-
processed and processed seeds of Stη1chons 
nux-vomtca m mice. 
B. Cai, T. Nagasawa, S. Kadota, M. Hattori, 
T. Namba and Y. Kuraishi. Biol. Pharm. Bull., 
18, 127-131, 1996. 
Summary: We examined the antinociceptive 
effects of the crude alkaloid fractions ( CAF) of nux 
vomica (the dried seeds of Strychnos nux vomica 
L.) and the influences of various processing 
91 
methods upon their antinociception in three analge-
sic tests in mice. In the tail-pressure test, the CAF 
(0.01 1 μg/kg, i.p.) of nux vomica that was un-
processed or treated with sand-, locorice , or vine-
gar and sand-processing showed clear antinocicep-
tion. The CAF (1 μg/kg, i.p.) of vinegar-processed 
nux vomica showed antinociception, without effects 
at lower doses of 0.01 and 0.1 mg/kg and those 
treated with urine-or urine and sand-processing 
were without effects at doses of 0.01 1 μg I kg. 
Morphine (2 mg I kg, s.c.) showed short -lasting 
antinociception, without effects at a dose of 1 μg/ 
kg. In the hot-plate test, the CAF (100 μg/kg, i.p) 
of nux vomica having undergone sand processing 
produced a significant antinociception, without 
effects at lower doses of 0.01 and 1 μg/kg. The 
CAF (0.01-100 μg/kg, i.p.) of nux vomica that was 
unprocessed or treated with oil or vinegar and sand 
processing and morphine (1 and 100 μg/kg, s.c.) 
were without effects. In the acetic acid induced 
writhing test, the CAF (1 μg/kg, i.p.) of nux vomica 
that was treated with sand-proessing significantly 
inhibited the writhing behavior, while those of nux 
vomica that was unprocessed or treated with oil-or 
vinegar and sand-processing and morphine were 
without effects at a dose of 1 μg/kg. The present 
results demonstrate the antinociceptive effects of 
the CAF of nux vomica and suggest that sand-
processing is good for the analgesic potency of nux 
vomica. It is also suggested that the CAF of nux 
vomica has distinct antinociceptive potency, even 
after treatment with licorice一， oiト， vinegarand 
sand-processing. 
II.樺みのメカニズムに関する研究
5 ) Expression of tachykinin receptor mRN A in 
dosal root ganglia of the mo田 e.
T. Andoh, T. Nagasawa and Y. Kuraishi. Mol. 
Brain Res., 35, 329-332, 1996. 
Summary : We examined whether mRN A coding 
for tachykinin NKl receptor is expressed in the 
dorsal root ganglion (DRG) of the mouse, using 
reverse transcription -polymerase chain reaction 
(RT PCR). Both the RT PCR of the total RNA 
from the DRGs using four pairs of primers and the 
digestion of these products with the restriction 
92 
enzymes gave the bands with predicted length. 
Further amplification (nested PCR) of the part of 
one PCR product also gave the band with predicted 
length. Southern blot hybridization of RT -PCR 
products of total RNA from the DRG and several 
CNS regions revealed that the expression level of 
NKl receptor mRNA in the DRG was similar to the 
cerebellum and less than the olfactory bulb, cere-
bral cortex, medulla oblongata and spinal cord. 
The present results suggest that NKl receptor 
mRNA isexpressed in the mouse DRG, although the 
level is relatively low. 
N.神経の分化，成長，再生のメカニズムに関する
研究
6) Expression of mRNA for a neuronal differen-
tiation factor, TA20, in developing rat brain. 
C. Tohda, S. Nagai, Y. Kuraishi and Y. 
Nomura. Neurosci. Res., 25, 129-135, 1996. 
Summary : In our previous study, a novel factor, 
TA20, was isolated from NG108 15 cells. The 
TA20 mRNA was increased by stimulation which 
also induced neuronal differentiation. Neuronal 
cells overexpressed with T A20 extended long neur-
ites and stopped cell growth (Tohda et al., 1995, 
Neurosci. Res ., 23: 21-27). We investigated the 
expression pattern of T A20 mRNA in developing 
rat brains to predict physiological roles of T A20. 
T A20 mRN A began to increase between embryonic 
days 13 and 16. TA20 mRNA was observed mainly 
in neocortical, hippocampal and precerebellar neur-
oepithelium on embryonic day 16. Although the 
level of T A30 mRN A in the cerebral cortex was 
higher before birth than after birth, the level in 
cerebellar Purkinje cells increased gradually even 
after birth. The high expression level of T A20 
mRNA in the hippocampus was maintained before 
and after birth .Thus, T A20 was expressed highly 
in brain regions in which neurons were changing 
morphologically and qualitatively, suggesting that 





































T. Andoh, T. Nagasawa, I. Saiki, K. Hayashi 
and Y. Kuraishi, Effect of 2-chloroadenosine 
and carageenan on substance P -induced 
scratching in mice. Jpn. J. Pharmacol., 71, 
Suppl. I, 302P(1996). 
When injected into the human skin, substance P 
(SP) produced an itch sensation , which is believed 
to be mediated by histamine liberated from mast 
cels. However, we have recently found in mice that 
SP elicits itch related behavior, which is inhibited 
by NKl receptor antagonist, and that SP induced 
such behavior even in mast cell deficient mice. As 
NKl receptors are expressed in macrophages 
(Mφ） , we examined whether Mφwould be 
involved in SP-induced itching in mice. In the pres-
ent experiments, SP (100 nmol) was intradermally 
injected into the rostral back of the male ICR (28 
32 g) mice and in one experiment mast cell defi-
cient mice (WBB6Fl羽「；wv,33-40 g). For itch-
related response, scratching of the injected site by 
either hind-paw was counted. Pretreatment with 
carrageenan (0.1-1.2 mg, i.p., -24 h) produced the 
dose dependent inhibition of SP-induced scratch司
ing. Pretreatment for 24 h with 2一chloroadenosine
(ChA, 5-50 mg, i.v., -24 h), but not adenosine (50 
mg, i.v., -24 h), also produced the dose dependent 
inhibition of the SP action. ChA (50 mg) inhibited 
the SP action in mast cell-deficient mice. As car-
rageenan and ChA are toxic to Mc,6, the present 
results suggest that乱fφareat least in part involved 





H.B.Yaakob, T. Nagasawa, T. Andoh and Y. 
Kuraishi, lntradermal injection of papain 
elicites scratching behaviors in mice.ゐn.J. 
Pharmacol., 71, Suppl. I, 302P(1996). 
Although pruritus is the common symptom of 
cutaneous diseases, the mechanisms are unclear. 
Papain, a protease, causes an itch sensations in 
human subjects when applied to the skin. In the 
present experiments, we examined whether papain 
would elicit itch related behaviors, that is, scratch-
ing in mice. Papain was intradermally injected into 
the rostral back of the male ICR mice (5 weeks old) 
and their behaviors were recorded using a video 
camera, which served for behavioral observation. 
Papain (1 -100 μg) dose dependently elicited the 
scratching of the injected skin by the hind paws; the 
number of scratching at papain dose of 100 μg was 
205.9 ± 42.7 per 60 min (nニ 8).Papain (100 μg) 
denatured by heat at 100℃ for 10 min was without 
effect. When coadministered with papain (100 μg), 
the protease inhibitor antipain (100 μg) significant-
ly suppressed the papain -induced scratching. 
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Pretreatment with capsaicin (50, 50, 100, 150 and 
200 mgkg-1day一1,s.c., daily for 5 days) significant-
ly inhibited papain (100 μg) induced scratching. 
These results demonstrated that papain induces 
scratching, which may be due to the sensory, prob-
ably itch, stimulation of the skin. It is suggested 
that the proteolytic activity is responsible for the 






















［結果・考察｝生理食塩水及びHST(1, 10, 100 μg) 
の注射後1時聞の引っ掻き行動の平均回数は， ICR系
マウスで各々 7,47, 70, 120固と用量依存的に増加し
たが， ddY系マウスでは各々 3,7,10,20固と少なかっ
た。一方， 5-HT (3, 10, 30 μg）のそれは， ICR系マ
ウスで各々 22,78, 112回， ddY系マウスで各々 14,47, 
146固と，何れも用量依存的に増加した。ICR系マウス
における HST(100 μg）誘発引っ撞き行動は， CPR













































6) Kuraishi Y., Urneno H., Nagasawa T., and 
Y arnazaki N. : An tinociceptive effects of 
repeated systemic injections of calcitonin, 
involving ascending serotonergic systems. 
1996 World Congress on Osteoporosis, 1996, 5, 

























Evans blue量から算出した permeabilityratio (PR) 
値を指標とした。
［結果） Papain (100 μg）注射後1時間の引っ掻き行
動は， 206± 43回であった。 L 668, 169 (5 nmol)を
papain (100 μg）と同時投与すると， 51っ掻き行動は


















学大会， 1996,7，神戸.Neurosci. Res. Supple., 
20 : 8213 (1996) 
We have found that facilitation of glutamatergic 
transmission in the spinal dorsal horn is suggested 
to be responsible for the repeated cold stress (RCS)-
induced hyperalgesia. In the present experiments, 
to determine whether the facilitation of the function 
of NMDA receptors in the spinal dorsal horn would 
be involved in this hyperalgesia, we investigated 
expression changes of mRNAs for four NMDA 
receptor subtypes, NR2A-2D, in the lumbar cord of 
RCS rats, using in situ hybridization. Three-day 
exposure to RCS decreased the nociceptive thresh-
old of the hind paw. It produced a significant 
increase in the expression of NR2C mRNA in the 
laminae I and I and tendency to increase in the 
laminae V and VI. Such increases were not appar-
ent 11 days after cessation of RCS, when the nocice-
ptive threshold recovered to normal. There was a 
tendency to increase in NR2B mRNA in the laminae 
I and I after 3-day exposure to RCS. There were 
no obvious alterations in the expression of mRN As 
for NR2 NR2C and NR2B in other laminae of the 
lumbar cord and those of NR2A and NR2D in al the 
laminae. These results suggest that RCS-induced 
hyperalgesia is mediated at least in part by the 
increased expr田sionof NMDA receptor subtypes, 




学大会， 1996,7，神戸.Neurosci. Res. Supple., 
20 : 8208 (1996) 
We have found that an intradermal (i.d.) injection! 
of serotonin (5-HT) induces itch related behavior, 
that is, scratching of the injection site by the hind 
paws in mica This study was conducted to deter-
mine which subtypes of 5-HT receptors would be 
involved in the 5-HT action. An i.d. injection was 
given to male ddY mice (4-5 weeks old) in a volume 
of 50 μ1. The behaviors were videotaped, which 
served for behavioral observation. An i.d. injection 
of 5-HT (1.4-140 nmol) and the 5HT2 agonist 
(methyl-5-HT (3-300 nmol)) produced the scratch-
ing in a dose-dependent manner, but the 5-HT1A 
agonistR(+)-8-0H-DPAT (0.1-lOOnmol) andthe 
5 HT3 agonists 1 phenylbiguanide (30-300 nmol) 
and 2-methyl-5-HT (30-300 nmol) were almost 
without effects. The scratching induced by 5-HT 
(100 nmol) was significantly inhibited by peroral 
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pretreatment with the 5-HT2 antagonists methyser-
gide (0.1-1 mg/kg) and cyproheptadine (0.1-1 mg/ 
kg) , but not with the 5-HT 3 antagonists ondan-
setron (0.01-1 mg/kg) and MDL-72222 (0.01-1 mg/ 
kg) . The present results suggest出atan i.d. i吋ec-
ti on of 5-HT elicits itch-related behavior mediated 









13) Kuraishi Y., Umeno H., Yamazaki N., and 
Nagasawa T.: Evidence for the involvement 
of ascending serotonergic systems in 
antinociception of repeated systemic injection 
of calcitonin in rats. 8 th World Congress on 
















として TJ-127を用いた。 RCSの負荷は， 10:00 16: 
30の聞は30分毎に飼育環境温度を 24℃と 4℃に交
互に変化きせ， 16:30 10 : 00の聞は4℃とし，これを
3日間繰返して行なった。 TJ-127は， 5%アラビアゴ
ムに懸濁して経口投与した。セロトニン神経毒5,7-
















より腰髄の5-HTを減少させておくと， TJ127 (300 
mg/kg）の抗侵害受容作用は有意に減弱した。しかし
6-0HDAの4日前処置により腰髄のNAを減少させ





































体作動薬R( + )-8-0H-DPAT (0.1-300 nmol)及び5-
HT3受容体作動薬2Me 5 HT (3-300 nmol) と1-
phenylbiguanide (3-300 nmol) は無効でおあった。 5-
HT (100 nmol)およびα－Me-5-HT(50 nmol)の樺
み関連行動惹起作用を 5HT2受容体桔抗薬meth司
ysergide (0.1-1 mg/kg p.o.）が抑制したが， 5HT3受


























nmol, 5分前処置）, cyproheptadine (3 nmol, 30分前
処置）, methiothepine (3 nmol, 30分前処置）も TJ
127の抗侵害受容作用を有意に抑制した。一方，カテコ











19) Andoh T., Nagasawa T., Hayashi K., and 
Kuraishi Y.: Endogenous nitric oxide modu-
lates substance P-induced itch-related behav-
ior. 26th Annual Meeting, Society of Neuros-
cience~ 1996, 11, Washington D.C., USA. 
Substance P (SP) causes an itch sensation in 
human subjects when applied to the skin. Recently 
we have shown that SP injected into the rostral part 
of the mouse back elicits scratching of the injection 
site by the hind paws, behaviors related to an itch 
sensation. Incidentlly, it has been reported that 
nitric oxide (NO) modulates several peripheral 
perception. Stimulation of NKl receptors activates 
nitric oxide synthase (NOS) and NO issynthesized 
from L arginine. The present experiments were 
conducted to determine whether the NO cyclic 
GMP pathway was involved in SP-induced scratch-
ing. Male ICR mice (5 6 weeks old) were used and 
SP was intradermally injected (50 μI) into the ros-
tral back. Pretreatment with NG nitro-L-arginine 
methyl ester (L NAME, i.v. for 5 min), an agent 
that inhibits NOS, significantly supressed SP (100 
nmol) induced scratching in a dose dependent 
manner, but not D-NAME. The second inhibitor of 
NO formation, 1 ethyl-2-thiourea had a similar 
inhibitory effect on SP induced scratching. Com 
comitant intradermal injection of SP (100 nmol) 
with haemoglobin (0.01 10 nmol), a scavenger of 
NO, or methylene blue (0.001 0.1 nmol), a guanylate 
cyclase inhibitor, significantly supressed SP-in-
duced scartching. 
20) Tohda C., Yamaguchi T., and Kuraishi Y.: 
Intracisternal injection of morphine induces 
facial scratching in mice. 26 th Annual Meet-
ing, Society of Neuroscience, 1996. 11. W a-
shington D.C., USA. 
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Epidural and intrathecal administrations of mor-
phine result in pruritus in humans, and the microin-
jection of opioid μ agonists into the medullary 
dorsal horn produces facial scratching in monkeys 
and rats. The present experiments were conducted 
to determine whether morphine and μ agonist, [D-
Ala2, N-Me Phe4, Gly5-ol] enkephalin (DAMGO) 
induced centrally itch related behavior, that is, 
scratching in mice. Male ddY mice 付近weeksold) 
were used. When intracisternally injected (5 μL), 
morphine (0.1 3 nmol) and DAMGO (0.03, 0.1 nmol) 
dose-dependently elicited scratching of face, but not 
ear and body trunk, by the hind paws for about 30 
min after injection. The morphine (0.3 nmol)-in-
duced face scratching was inhibited by pretreat-
ment with naloxone (1 mg/kg, s.c., 15 min before). 
When injected intradermally, morphine (3, 30 nmol, 
50 mL) into the rostral back didn’t significantly 
elicit scratching of any areas of the body. These 
results suggest that opioids produce an itch sensa-
tion at least in part through opioid μ receptors in 
the central nervous system in mice. The present 
experimental model is easy to use and seems to be 
available to clarify central mechanisms of itch. 
く〉 講演，社会活動，その他
1) Kuraishi Y., Onogi T., and Satoh M.: A mecha-
nism of antinociceptive action of (6)-shogaol, 
a pungent component of ginger. Advances in 
Research on Pharmacologically Active sub-





系の関与．和漢医薬学雑誌， 12(4)' 368 369, 1995. 
4）長津哲郎：庫みとその治療薬．平成8年度富山県
リカレント教育学習コース講義テキスト 和漢薬
に未来はあるか， 5660, 1996. 
